Abstract
Introduction: The UK government introduced the two-week rule (TWR) to improve the diagnosis and treatment of gastrointestinal (GI) cancers. This updated review systematically identifies new articles since 2009 and presents an overview of the previous and new findings combined for both upper GI cancer (UGCs) and colorectal cancers (CRCs).
Methods: We analysed all peer-reviewed articles and conference abstracts with GI cancer detection rates following TWR referral and/or the proportion of TWR-referred GI cancers from the total number diagnosed during the study period. We reported average cancer detection rates and split the data according to four time periods to determine whether TWR effectiveness improved over time.
Results: The average cancer detection rate by the TWR for all studies was 11.6% for CRC and 8.3% for UGC. We found a decrease in cancer detection rates over time for CRC from 14.4% in 2000-2002 to 7.2% in 2009-2012. However, UGC detection rates increased over time from 8.5% in 2000-2002 to 11.4% in 2005-2008. We found that on average, 30.8% of CRCs and 28.8% of UGCs were detected following referrals using the TWR system and that these proportions had increased over time from 30.6% to 38.4% for CRC and from 26.8% to 52% for UGC.
Conclusion: The TWR is not still sufficiently effective in diagnosing GI cancers in patients, suggesting that the referral guidelines need to be improved. Our findings do suggest that the TWR is being used more frequently than alternative routes.
Keywords: Gastrointestinal cancer, two-week referral, fast-track, cancer detection rate.
Current Cancer Therapy Reviews
Title:Has the Two Week Rule Improved Cancer Detection Rates for Gastrointestinal Cancers? A Systematic Literature Review
Volume: 10 Issue: 1
Author(s): Kymberley Thorne, Hayley A. Hutchings and Glyn Elwyn
Affiliation:
Keywords: Gastrointestinal cancer, two-week referral, fast-track, cancer detection rate.
Abstract: Introduction: The UK government introduced the two-week rule (TWR) to improve the diagnosis and treatment of gastrointestinal (GI) cancers. This updated review systematically identifies new articles since 2009 and presents an overview of the previous and new findings combined for both upper GI cancer (UGCs) and colorectal cancers (CRCs).
Methods: We analysed all peer-reviewed articles and conference abstracts with GI cancer detection rates following TWR referral and/or the proportion of TWR-referred GI cancers from the total number diagnosed during the study period. We reported average cancer detection rates and split the data according to four time periods to determine whether TWR effectiveness improved over time.
Results: The average cancer detection rate by the TWR for all studies was 11.6% for CRC and 8.3% for UGC. We found a decrease in cancer detection rates over time for CRC from 14.4% in 2000-2002 to 7.2% in 2009-2012. However, UGC detection rates increased over time from 8.5% in 2000-2002 to 11.4% in 2005-2008. We found that on average, 30.8% of CRCs and 28.8% of UGCs were detected following referrals using the TWR system and that these proportions had increased over time from 30.6% to 38.4% for CRC and from 26.8% to 52% for UGC.
Conclusion: The TWR is not still sufficiently effective in diagnosing GI cancers in patients, suggesting that the referral guidelines need to be improved. Our findings do suggest that the TWR is being used more frequently than alternative routes.
Export Options
About this article
Cite this article as:
Thorne Kymberley, Hutchings A. Hayley and Elwyn Glyn, Has the Two Week Rule Improved Cancer Detection Rates for Gastrointestinal Cancers? A Systematic Literature Review, Current Cancer Therapy Reviews 2014; 10 (1) . https://dx.doi.org/10.2174/157339471001140815152459
DOI https://dx.doi.org/10.2174/157339471001140815152459 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Related Books
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer
Current Gene Therapy Neurotoxins: Free Radical Mechanisms and Melatonin Protection
Current Neuropharmacology Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Current Cancer Drug Targets Surface Markers of Cancer Stem Cells in Solid Tumors
Current Stem Cell Research & Therapy Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Endocrine, Metabolic & Immune Disorders - Drug Targets Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic Resection
Current Medical Imaging Transcriptional Regulation of Antimicrobial Host Defense Peptides
Current Protein & Peptide Science Patent Selections:
Recent Patents on Biomarkers Microalgal Fatty Acids and Their Implication in Health and Disease
Mini-Reviews in Medicinal Chemistry Biomarker Discovery and Translation in Metabolomics
Current Metabolomics Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design A Review of Medicinal Plant Patents
Recent Patents on Biomedical Engineering (Discontinued) Current Scenario of Acridine Hybrids with Anticancer Potential
Current Topics in Medicinal Chemistry The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
Current Cancer Drug Targets Current Applications of Artificial Neural Networks in Biochemistry with Emphasis on Cancer Research
Current Biochemical Engineering (Discontinued) Research Progress of Glycyrrhizic Acid on Antiviral Activity
Mini-Reviews in Medicinal Chemistry Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Discovery of Medically Significant Lantibiotics
Current Drug Discovery Technologies